- Does My Child Have a Language Disorder?
- Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay
- ASCs’ vendor problem
- Providence’s physician chief on its ‘holistic’ approach to value-based care
- What the Health? From KFF Health News: A New CDC Nominee, Again
- States Update Guardianship Laws To Keep Children of Immigrants Out of Foster Care
- Anesthesia job market faces ‘major disruption’
- Florida system raises $100M for new ED
- North Carolina system names COO
- Mark Cuban wants to bring drug manufacturing to hospitals’ doorsteps — literally
- UCI Health names chief AI officer
- Nevada hospital names CEO
- Saint Luke’s taps president for 2 hospitals
- Dental community mourns dentist killed in murder-suicide
- Mass General Brigham, CVS deal could raise healthcare spending $40M annually: Report
- Ideal Dental opens 1st Oklahoma practice, expands in 2 more states
- PDS Health eyes the next era of medical-dental integration
- Mark Cuban dives into direct contracting
- HCA executive pay by the numbers
- Iris Telehealth offers behavioral health analytics platform
- HHS names chief economist, regulatory leader to address healthcare affordability
- Loma Linda University Health names new president
- The best ASCs for colonoscopy, endoscopy in the South: US News
- Tennessee moves forward with CON repeal
- Dental schools take action to alleviate workforce shortages: 6 updates
- American Medical Group Association partners with Talkiatry to expand psych access
- Trump nominates CDC director
- ChristianaCare, Cardiovascular Physicians of Delaware to open joint venture ASC
- 5 states regulating AI in mental health
- Centerstone debuts $13M youth behavioral health campus in Missouri
- 3 DSOs making headlines
- Maine restricts noncompetes for rural healthcare workers
- Heartland Dental opens Florida office
- The 10 biggest ASC deals of the last 5 years
- Affordability, transparency: A look at large employers' top healthcare concerns
- 10 dental Medicaid updates to know from Q1
- White House eyes ibogaine research expansion
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Trump Names CDC Director Pick
- SocialRx teams up with FQHC in NYC to prescribe arts and culture for chronically ill patients
- FDA To Review Whether To Allow More Access To Certain Peptides
- Rising Colon Cancer Deaths Hit Younger Adults Without Degrees Hardest
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Over 80% of PCPs concerned about financial stability over next several years
- Industry Voices—DOJ jumps into 340B cases over state law, raising questions about federal plans for the program
- FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER
- Most People Would Take A Blood Test For Alzheimer's, Study Says
- This Sexually Transmitted Infection Linked To Heart Attack, Stroke
- How Playtime at Age 2, Especially with Parents, Shapes Teen Fitness Habits
- New Depression Treatment Matches ECT with Less Memory Loss, Study Says
- Memory Problems? Your Salt Intake Could Make Matters Worse, Study Says
- Ultra-Processed Foods Linked To Fatty Muscles, Potential Knee Arthritis
- Your New Therapist: Chatty, Leaky, and Hardly Human
- Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat
- Gen AI chatbots continually struggle with differential diagnoses, Mass General Brigham study finds
- Listen: With Little Federal Regulation, States Are Left To Shape the Rules on AI in Health Care
- Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale
- BIO comes out swinging with 'Fight of Our Lives' campaign for the industry’s 50th birthday
- The future of medical-dental integration is here
- Texas dentist has license suspended
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- What’s the deal with insurer mental health parity violations?
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign
- 10 trends in behavioral health usage: Report
- Cattywampus: Statement on the CAT Concept Release
- Providers' advantage on out-of-network billing disputes likely to continue: Capstone
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- EPA Delays Decisions on 'Forever Chemicals'
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Progyny unveils new fertility benefit option for small, mid-size employers
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- Hospitals with more disadvantaged patients fall short on price transparency, study finds
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- Listen to the Latest ‘KFF Health News Minute’
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Does Your Child Have Nightmares? Here's One Solution
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- Statement Regarding Staff No-Action Letter to Bank of England
The National Bureau of Economic Research (NBER) is a nonprofit economic research organization tightly connected to Federal economic policymakers, especially the Council of Economic Advisers. NBER dates back to 1920 and is associated with progressive era (think Woodrow Wilson and FDR) economic policies. The NBER is best known as the official arbiter of when economic recessions begin and end in the United States.
Raymond Kluender of Harvard, Neale Mahoney of Stanford, Francis Wong of CES at Ludwig-Maximilians-Universität München, and Wesley Yin of UCLA partnered with RIP Medical Debt to conduct two randomized experiments that relieved medical debt with a face value of $169 million for 83,401 people between 2018 and 2020. They reported the very surprising results of two randomized experiments in NBER Working Paper 32315:
http://www.nber.org/papers/w32315
Their findings:
1. No impact of debt relief on credit access, utilization, and financial distress on average.
2. Debt relief causes a moderate but statistically significant reduction in payment of existing medical bills.
3. No effect of medical debt relief on mental health, and detrimental effects for some groups!
An article on the study in Vox, a PC screed which targets youth:
https://www.vox.com/future-perfect/24146373/medical-bills-debt-relief-credit-score-health-care
What if canceling people’s medical debt doesn’t help them?
A shocking new study suggests medical debt relief didn’t do much to improve patients’ finances or health.
By Dylan Scott - May 2, 2024Four in 10 Americans carry some kind of medical debt, an affliction that is unique to the United States among wealthy nations. The country does not guarantee medical insurance to everyone, and the costs even to people who carry coverage are much higher on average than they are for patients in the rest of the developed world. It’s a fundamental flaw in the design of the US health care system.
Those debts weigh on the people who carry them: Research has found that people who incur substantial medical bills (after a cancer diagnosis, for example) report cutting back on everyday spending, depleting their savings, and even downsizing their homes. Medical debt is associated with poorer general health, as well as higher rates of cancer, heart disease, and overall mortality. People end up sicker because they can’t afford their health care.
In the absence of politically difficult health care reform, activists and some state and local governments have set up medical debt relief programs, purchasing the debts of people in difficult financial circumstances for much less than face value and wiping them out at no cost to the patient.
But a new study of medical debt relief by a group of top economists has called its value into question. Participants who had their debt erased did not see their mental or physical health or their access to credit improve much after debt relief. There was even evidence that some people felt more depressed.
“It would be great if we could improve people’s mental health, we could ease their finances, we could get them to go to the doctor more often by buying debt for less than a penny on a dollar,” Francis Wong, a University of Munich economist who co-authored the study, told me. “But it just didn’t work.”
The findings stunned the researchers. While it might still be premature to discard medical debt relief based on one study, the research raises important questions about the limits of debt relief, and about how to use finite government and philanthropic resources to alleviate high health care costs.
One lesson of the paper may be that relieving debt long after it’s accrued is ultimately a Band-Aid on the structural problems within US health care. Many people with medical debt are contending with other financial problems compounded by their health expenses, which are not easily undone by eliminating hospital bills. Preventing medical debt in the first place may be more effective.
“The punchline for me is that you really need to tackle the root cause that created all of these issues in the first place, that created the financial distress and poor mental health,” Wong said. “That’s a matter of addressing the holes in the American health care system.”
Medical debt relief didn’t do much to improve people’s finances
The research team — including Wong, Harvard’s Raymond Kluender, Stanford’s Neale Mahoney, and UCLA’s Wesley Yin — was commissioned to study a group of 83,400 people who collectively had $169 million in medical debt relieved through the organization RIP Medical Debt (recently renamed Undue Medical Debt). The study analyzed two groups of patients: one had held their debts for seven years on average, the other for a little more than a year. Using surveys and financial data, the experiment tracked most patients for about a year after they received debt relief.
Compared to patients who did not have their debt wiped out, the researchers found, the relief had negligible effects on participants’ access to credit and other measures of financial well-being. Credit scores increased by a marginal 3.6 points on average, though for people whose only debt had been medical debt, there was a more sizable 13.4-point increase. The average increase in credit limits was just $342.
Participants whose debt was relieved actually became less likely to pay future medical bills, the study found. The results showed no improvements in objective and subjective measures of financial distress.
One reason may be that although participants had an average of $2,167 in debt relieved, they had plenty of other, non-medical debt. The group averaged $28,000 in debts including things like credit card balances and car loans. An average of $4,000 in bills had already reached collections.
“The most striking thing to me was just how much financial distress that folks with medical debt are experiencing broadly,” Kluender said. “The debt relief that we were able to execute through the experiment was insufficient to address their financial deprivation.” People in medical debt are often pestered by collectors and forced into even more debt to pay their bills and cut their spending on necessities such as food and rent.
People did not report feeling happier or healthier after debt relief
The study also found that measures of depression, stress, anxiety, subjective feelings of well-being, and general health barely budged after debt was wiped out.
One finding is especially telling. Before the experiment began, the authors asked a panel of 45 experts what they expected the study to find. Panelists anticipated on average a 7 percentage point reduction in the number of patients reporting moderate or worse depression. Instead, the study showed a 3.2-percentage point increase in patients reporting that they were depressed. That’s on top of the 45 percent of participants who reported having at least moderate depression before the experiment began.
The worst mental health effects were found among the 25 percent of participants with the most medical debt: They experienced a 12.4-percent increase in depression along with “worsening of anxiety, stress, general health, and subjective well-being” after debt relief.
“That’s just staggeringly high rates of poor mental health,” Wong said.
How can that be? One possibility is that the relief came too late to undo the severe mental health burden of carrying debt for months or years. Such patients have “already been scarred by the collection process,” Mahoney told me, and will continue to struggle with non-medical debts.
“That’s the sort of person who on a weekly basis is getting hounded by debt collectors, not just sort of the medical debt collectors that we study, but debt collectors of all sorts,” Wong said. Medical debt relief “really doesn’t do anything to alleviate any of those other conditions, not to mention whatever health condition led them to incur medical debt in the first place.”
The researchers identified another plausible theory through a sub-experiment included in the study, which tested the reactions of patients based on how they were informed of their debt relief, either by phone call or by letter. Among the people who received a direct phone call to let them know, the negative mental health effects were greater.
Prior research has found that Americans tend to feel shame and stigma when receiving charitable or government aid to pay their bills. Participants had not requested debt relief, the study noted, but rather had it purchased and wiped out by RIP Medical Debt without their prior knowledge (this is often how medical debt relief programs work). It’s possible that the very act of filling out the study’s surveys may have affected how the respondents perceived their own situation.
“We’re reminding people of this unpleasant experience that they had,” Kluender told me. “And maybe they were going through some unpleasant negotiations with their insurer or they feel a lot of guilt and shame about being unable to pay the bill.”
What do we do with this information?
The disappointing findings are especially surprising in light of research on relief programs for other types of debt, like credit card debt and student loan debt, that has found improvements in financial health and job prospects. Medical debt, like those other types of debt, has been associated with worse health and a weaker financial situation.
But medical debt has some distinct characteristics. Repayment rates are much lower than they are for student loans or mortgages. Once a medical bill reaches collections, it’s often resolved with a negotiated settlement, which can result in much lower payments than what the patient originally owed.
So the study participants, who had carried their debt for more than a year at a minimum, may have already been subconsciously writing off the medical debt by the time relief came, the authors said. That limits the impact they may feel when it’s wiped out.
Some experts not involved in the study think the findings may understate the benefits of medical debt relief, especially on people’s finances, based on earlier studies of medical debt relief that had found larger benefits for people’s credit scores and credit access.
The effect on credit scores is increasingly a moot point, however. Credit agencies have agreed to stop reporting most medical debt on people’s credit reports, after urging from the Biden administration, a step taken in the midst of the experiment. (The study relied on a subset of people whose debt was relieved prior to that announcement.)
Amy Finkelstein, a leading researcher on health care costs at MIT whose nonprofit J-PAL North America helped fund the study, said she was shocked by the results but grateful to have them. Part of the difficult work of policymaking is to soberly assess the results of what you are doing.
“Yes, it’s disappointing. But another way of saying it is: This was true whether or not we had done the study,” Finkelstein told me. “So it’s good to know so that we can try to learn from it and move on.”
Everybody I spoke to agreed on one thing: Preventing people from accruing medical debt in the first place would likely be more effective in improving their finances and health than relieving debts after the fact. One-time debt relief may not make it any easier or less stressful to access health care in the future, but providing people with health coverage that eliminates the risk of debt does.
That hypothesis is supported by existing evidence. The Oregon Health Insurance Experiment, a totemic work in health care research, found that low-income adults who received Medicaid saw a 9 percent reduction in depression. They were also less likely to end up in debt because of a medical bill and less likely to take out loans or skip payments on their other necessities to cover their health care balance.
Experts I spoke to named more robust interventions that could lead to less medical debt and better health and financial outcomes, including more generous insurance benefits for people already covered.
Covering the 26 million Americans who remain uninsured would be another step. Most states in the Deep South still haven’t expanded Medicaid under the Affordable Care Act (ACA), leaving millions of low-income people without coverage. Other proposals, such as more public insurance options, have gained increasing support among Democrats.
“As a consumer advocate, the best solution would be single-payer, Medicare for all,” Chi Chi Wu, an attorney with the National Consumer Law Center, said.
But major overhauls are easier said than done. The history of US health care reform is one of a country inching toward universal health coverage: Medicare and Medicaid passed in the 1960s, and the ACA didn’t come along until 2010. Our byzantine insurance system with weak cost controls persists, with a massive health care industry invested in maintaining the status quo.
In the meantime, experts said, policymakers could focus on making sure that hospital financial assistance programs are accessible to more people. Many patients are eligible for aid that would significantly reduce what they owe — but they often have no idea it’s available. The New York Times reported in 2022 that some hospitals were making it extremely difficult for eligible patients to find out about and use assistance programs, while aggressively seeking payment even from patients who should qualify for aid.
The long-term project of universal health care continues. The debt relief study, disappointing as its results might be, may spur some fresh thinking about how to better help people.
This study and its findings won't faze RIP Medical Debt or its many programs in Michigan.
I did not expect this. But in the context of human nature, it does make sense.
We were made for personal responsibility. When the ability to meet our obligations is taken away by unjust law, feeling grateful for a bail-out may just possibly be a bridge too far.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














